<DOC>
	<DOCNO>NCT01144793</DOCNO>
	<brief_summary>The purpose study measure , pilot/observational study , panel circulate protein real time onset neutropenic fever/infection patient acute chronic leukemia undergo chemotherapy biologic treatment . And generate preliminary trend result panel circulate protein longitudinally period neutropenia correlate value clinical/laboratory data patient outcome .</brief_summary>
	<brief_title>Biomarker To Evaluate Protein Profiles Neutropenic Fever/Infection With Acute Chronic Leukemias</brief_title>
	<detailed_description>To identify potential biomarkers prediction NF , perform serial measurement nine biomarkers [ C-reactive protein ( CRP ) , protein C , interleukin ( IL ) -6 , IL-8 , IL-10 , IL-1β , tumor necrosis factor-α , monocyte chemotactic protein-1 , intercellular adhesion molecule-1 ] use multiplex ELISA array platform every 6-8 hour patient undergo myelosuppressive chemotherapy hematologic malignancy .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Febrile Neutropenia</mesh_term>
	<criteria>Age &gt; = 18 Preadmission ( ATU , ITA ) inpatient status absolute neutrophil count ( ANC ) &lt; = 1500/mm^3 Patients acute myeloid lymphoid leukemia : admit newly diagnose disease yet receive induction chemotherapy admit neutropenic fever receive postremission chemotherapy admit postremission chemotherapy Patients chronic myeloid leukemia chronic lymphoid leukemia/disorder receive chemotherapy diseasespecific treatment last 30 day ANC &lt; =1500/mm3 consider treat physician least possibly treatmentrelated An intravenous line catheter ( Hickman , port , portacath , peripherally inserted central venous catheter [ PICC ] line ) must place time protocol participation/study start , insert solely purpose study . Whenever possible , patient consent blood monitoring initiate first dose antibiotic , possible , time standard care measure delay interrupt purpose study enrollment . Patients must able understand nature study give write informed consent . There exclusion criterion . Anyone meet inclusion criterion exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>